Working… Menu

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting (SIMPLICITY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01244750
Recruitment Status : Unknown
Verified January 2018 by Bristol-Myers Squibb.
Recruitment status was:  Active, not recruiting
First Posted : November 19, 2010
Last Update Posted : January 23, 2018
ICON Clinical Research
Information provided by (Responsible Party):
Bristol-Myers Squibb